Eli Lilly and Company
2,3-dihydrofuro[2,3-b]pyridine compounds
Last updated:
Abstract:
The present invention provides a compound of Formula I: wherein R is H or F; or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treatment of neurodegenerative diseases, such as Alzheimer's disease. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
14 Jun 2019
Issue date:
4 Jan 2022